Patents by Inventor Benoit de Chassey

Benoit de Chassey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRROLE-TYPE COMPOUNDS AND USES THEREOF FOR TREATING VIRAL INFECTIONS
    Publication number: 20240002370
    Abstract: The present invention relates to pyrrole-type compounds of formula (I) and pharmaceutical compositions comprising the same. The invention further relates to such compounds and pharmaceutical compositions for use for treating a viral infection and/or cancer.
    Type: Application
    Filed: December 2, 2021
    Publication date: January 4, 2024
    Inventors: JACKY VONDERSCHER, BENOÎT DE CHASSEY, LAURÈNE MEYNIEL-SCHICKLIN, FRÉDÉRIC MIEGE
  • Non-fused thiophene derivatives and their uses
    Patent number: 11840527
    Abstract: The present invention relates to a new class of non-fused thiophene derivatives and their uses for treating diseases such as infection, cancer, metabolic diseases, cardiovascular diseases, iron storage disorders and inflammatory disorders.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: December 12, 2023
    Assignee: ENYO PHARMA
    Inventors: Eric Meldrum, Benoît De Chassey, Peter Machin, Karine Fabienne Malagu, Paul Colin Michael Winship, Mark Chambers, Jamie David Knight, Roberta Lanaro
  • Thiophene derivatives as antiviral agents
    Patent number: 11807618
    Abstract: The present invention relates to a new class of compounds having an antiviral effect and the uses thereof.
    Type: Grant
    Filed: March 18, 2022
    Date of Patent: November 7, 2023
    Assignee: ENYO PHARMA
    Inventors: Eric Meldrum, Benoît De Chassey, Laëtitia Lines, Jérôme Amaudrut, Benaissa Boubia, Vincent Derain, Fabrice Guillier, Christian Montalbetti, Calum Macleod, Karine Fabienne Malagu, David Robert Vesey, Paul Colin Michael Winship
  • Non-fused thiophene derivatives and their uses
    Patent number: 11767316
    Abstract: The present invention relates to a new class of non-fused thiophene derivatives and their uses for treating diseases such as infection, cancer, metabolic diseases, cardiovascular diseases, iron storage disorders and inflammatory disorders.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: September 26, 2023
    Assignee: ENYO PHARMA
    Inventors: Eric Meldrum, Benoît De Chassey, Peter Machin, Karine Fabienne Malagu, Paul Colin Michael Winship, Jean-Laurent Paparin, Mark Chambers, Jamie David Knight, Roberta Lanaro
  • QUINAZOLINONE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER
    Publication number: 20230150978
    Abstract: The present invention relates to a new class of quinazolinone derivatives of formula (I), and their uses for treating a cancer. The present invention further relates to pharmaceutical compositions comprising compounds of formula (I).
    Type: Application
    Filed: March 29, 2021
    Publication date: May 18, 2023
    Inventors: LAURÈNE MEYNIEL-SCHICKLIN, PETER MACHIN, ERIC MELDRUM, BENOÎT DE CHASSEY, FABRICE GUILLIER, CHRISTINE MASSARDIER, JÉRÔME AMAUDRUT, CHRISTIAN MONTALBETTI, DAVID COUSIN, JEAN-LAURENT PAPARIN
  • Fused thiophene derivatives and their uses
    Patent number: 11603368
    Abstract: The present invention relates to a new class of fused thiophene derivatives and their uses for treating diseases such as infection, cancer, metabolic diseases, cardiovascular diseases, iron storage disorders and inflammatory disorders.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: March 14, 2023
    Assignee: ENYO PHARMA
    Inventors: Eric Meldrum, Benoît De Chassey, Peter Machin, Roberta Lanaro, Calum Macleod, Karine Fabienne Malagu, Nicolas Proisy, David Robert Vesey, Paul Colin Michael Winship, Mark Chambers, Jean-Laurent Paparin
  • Fused thiophene derivatives and their uses
    Patent number: 11492347
    Abstract: The present invention relates to a new class of fused thiophene derivatives and their uses for treating diseases such as infection, cancer, metabolic diseases, cardiovascular diseases, iron storage disorders and inflammatory disorders.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: November 8, 2022
    Assignee: ENYO PHARMA
    Inventors: Eric Meldrum, Benoît De Chassey, Peter Machin, Roberta Lanaro, Calum MacLeod, Karine Fabienne Malagu, Nicolas Proisy, David Robert Vesey, Paul Colin Michael Winship, Mark Chambers
  • TERTIARY AMINE DERIVATIVES AND THEIR USES FOR TREATING A VIRAL INFECTION
    Publication number: 20220251028
    Abstract: The present invention relates to a new class of tertiary amine derivatives of formula (I) and their uses for treating viral infections, particularly viral respiratory infections. The present invention further relates to pharmaceutical compositions comprising compounds of formula (I).
    Type: Application
    Filed: June 25, 2020
    Publication date: August 11, 2022
    Inventors: ERIC MELDRUM, PETER MACHIN, BENOÎT DE CHASSEY, DAVID COUSIN
  • THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS
    Publication number: 20220213053
    Abstract: The present invention relates to a new class of compounds having an antiviral effect and the uses thereof.
    Type: Application
    Filed: March 18, 2022
    Publication date: July 7, 2022
    Inventors: ERIC MELDRUM, BENOÎT DE CHASSEY, LAËTITIA LINES, JÉRÔME AMAUDRUT, BENAISSA BOUBIA, VINCENT DERAIN, FABRICE GUILLIER, CHRISTIAN MONTALBETTI, CALUM MACLEOD, KARINE FABIENNE MALAGU, DAVID ROBERT VESEY, PAUL COLIN MICHAEL WINSHIP
  • Thiophene derivatives as antiviral agents
    Patent number: 11279683
    Abstract: The present invention relates to a new class of compounds of formula (I) having an antiviral effect and the uses thereof.
    Type: Grant
    Filed: December 28, 2017
    Date of Patent: March 22, 2022
    Assignee: ENYO PHARMA
    Inventors: Eric Meldrum, Benoit De Chassey, Laetitia Lines, Jerome Amaudrut, Benaissa Boubia, Vincent Derain, Fabrice Guillier, Christian Montalbetti, Calum MacLeod, Karine Fabienne Malagu, David Robert Vesey, Paul Colin Michael Winship
  • USE OF MODULATORS OF NEET PROTEINS FOR THE TREATMENT OF INFECTION
    Publication number: 20210038566
    Abstract: The present invention relates to the use of modulators of NEET proteins for the treatment of infection, in particular viral or bacterial infection.
    Type: Application
    Filed: February 8, 2019
    Publication date: February 11, 2021
    Inventors: ERIC MELDRUM, BENOÎT DE CHASSEY
  • NON-FUSED THIOPHENE DERIVATIVES AND THEIR USES
    Publication number: 20210040059
    Abstract: The present invention relates to a new class of non-fused thiophene derivatives and their uses for treating diseases such as infection, cancer, metabolic diseases, cardiovascular diseases, iron storage disorders and inflammatory disorders.
    Type: Application
    Filed: February 8, 2019
    Publication date: February 11, 2021
    Inventors: ERIC MELDRUM, BENOÎT DE CHASSEY, PETER MACHIN, KARINE FABIENNE MALAGU, PAUL COLIN MICHAEL WINSHIP, JEAN-LAURENT PAPARIN, MARK CHAMBERS, JAMIE DAVID KNIGHT, ROBERTA LANARO
  • NON-FUSED THIOPHENE DERIVATIVES AND THEIR USES
    Publication number: 20200369655
    Abstract: The present invention relates to a new class of non-fused thiophene derivatives and their uses for treating diseases such as infection, cancer, metabolic diseases, cardiovascular diseases, iron storage disorders and inflammatory disorders.
    Type: Application
    Filed: February 8, 2019
    Publication date: November 26, 2020
    Inventors: ERIC MELDRUM, BENOÎT DE CHASSEY, PETER MACHIN, KARINE FABIENNE MALAGU, PAUL COLIN MICHAEL WINSHIP, MARK CHAMBERS, JAMIE DAVID KNIGHT, ROBERTA LANARO
  • FUSED THIOPHENE DERIVATIVES AND THEIR USES
    Publication number: 20200369682
    Abstract: The present invention relates to a new class of fused thiophene derivatives and their uses for treating diseases such as infection, cancer, metabolic diseases, cardiovascular diseases, iron storage disorders and inflammatory disorders.
    Type: Application
    Filed: February 8, 2019
    Publication date: November 26, 2020
    Inventors: ERIC MELDRUM, BENOÎT DE CHASSEY, PETER MACHIN, ROBERTA LANARO, CALUM MACLEOD, KARINE FABIENNE MALAGU, NICOLAS PROISY, DAVID RICHARD VESEY, PAUL COLIN MICHAEL WINSHIP, MARK CHAMBERS, JEAN-LAURENT PAPARIN
  • FUSED THIOPHENE DERIVATIVES AND THEIR USES
    Publication number: 20200361924
    Abstract: The present invention relates to a new class of fused thiophene derivatives and their uses for treating diseases such as infection, cancer, metabolic diseases, cardiovascular diseases, iron storage disorders and inflammatory disorders.
    Type: Application
    Filed: February 8, 2019
    Publication date: November 19, 2020
    Inventors: ERIC MELDRUM, BENOÎT DE CHASSEY, PETER MACHIN, ROBERTA LANARO, CALUM MACLEOD, KARINE FABIENNE MALAGU, NICOLAS PROISY, DAVID RICHARD VESEY, PAUL COLIN MICHAEL WINSHIP, MARK CHAMBERS
  • THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS
    Publication number: 20190352275
    Abstract: The present invention relates to a new class of compounds of formula (I) having an antiviral effect and the uses thereof.
    Type: Application
    Filed: December 28, 2017
    Publication date: November 21, 2019
    Inventors: ERIC MELDRUM, BENOIT DE CHASSEY, LAETITIA LINES, JEROME AMAUDRUT, BENAISSA BOUBIA, VINCENT DERAIN, FABRICE GUILLIER, CHRISTIAN MONTALBETTI, CALUM MACLEOD, KARINE FABIENNE MALAGU, DAVID ROBERT VESEY, PAUL COLIN MICHAEL WINSHIP
  • Methods and Pharmaceutical Composition for the Treatment of Polyomavirus Infections
    Publication number: 20160250245
    Abstract: The present invention relates to methods and pharmaceutical compositions for the treatment of polyomavirus infections. In particular, the present invention relates to a method for treating a polyomavirus infection in a subject in need thereof comprising administering the subject with a therapeutically effective amount of gemcitabine.
    Type: Application
    Filed: October 20, 2014
    Publication date: September 1, 2016
    Inventors: Vincent Lotteau, Patrice Andre, Benoit De Chassey, Laurene Meyniel-Schicklin, Irene Pilar Castellanos
  • Methods and pharmaceutical compositions for inhibiting influenza viruses replication
    Patent number: 9168236
    Abstract: The present invention relates to methods and pharmaceutical compositions for inhibiting influenza virus replication. More particularly, the present invention relates to a compound selected from the group consisting of Gemcitabine, Obatoclax Mesylate, Docetaxel, HA-14, Alsterpaullone, GSK3B inhibitor VIII, GSK3B inhibitor XV, Indirubin 3?-monoxime, L glutathione reduced, Fluocinolone acetonide, Tirofiban, Topotecan hydrochloride, Clofarabine, Vinblastine, Menadione Crystalline and derivatives or analogues thereof for use in the treatment of an influenza infection in a subject in need thereof.
    Type: Grant
    Filed: April 10, 2012
    Date of Patent: October 27, 2015
    Assignees: Institut National de la Santé et de la Recherche Médicale (INSERM), Université Claude Bernard - Lyon 1
    Inventors: Vincent Lotteau, Benoit De Chassey, Patrice Andre, Laurene Meyniel-Schicklin, Anne Aublin-Gex
  • METHODS FOR SCREENING SUBSTANCES CAPABLE OF MODULATING THE REPLICATION OF AN INFLUENZA VIRUS
    Publication number: 20140296106
    Abstract: The present invention relates to methods for screening substances capable of modulating the replication of an influenza virus.
    Type: Application
    Filed: May 16, 2012
    Publication date: October 2, 2014
    Applicant: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
    Inventors: Vincent Lotteau, Benoit De Chassey, Patrice Andre, Chantal Rabourdin-Combe, Lionel Tafforeau, Thibault Chantier, Anne Aublin-Gex
  • METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING INFLUENZA VIRUSES REPLICATION
    Publication number: 20140030224
    Abstract: The present invention relates to methods and pharmaceutical compositions for inhibiting influenza virus replication. More particularly, the present invention relates to a compound selected from the group consisting of Gemcitabine, Obatoclax Mesylate, Docetaxel, HA-14, Alsterpaullone, GSK3B inhibitor VIII, GSK3B inhibitor XV, Indirubin 3?- monoxime, L glutathione reduced, Fluocinolone acetonide, Tirofiban, Topotecan hydrochloride, Clofarabine, Vinblastine, Menadione Crystalline and derivatives or analogues thereof for use in the treatment of an influenza infection in a subject in need thereof.
    Type: Application
    Filed: April 10, 2012
    Publication date: January 30, 2014
    Applicant: UNIVERSITÉ CLAUDE BERNARD - LYON 1
    Inventors: Vincent Lotteau, Benoit De Chassey, Patrice Andre, Laurene Meyniel-Schicklin, Anne Aublin-Gex